Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) Revenue: 2020-2025

Historic Revenue for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to $196.26.

  • Molecular Partners Ag's Revenue fell 75.03% to $196.26 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 2.61%. This contributed to the annual value of $5.6 million for FY2024, which is 27.91% down from last year.
  • According to the latest figures from Q3 2025, Molecular Partners Ag's Revenue is $196.26, which was down 100.00% from $4.2 million recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Revenue peaked at $196.6 million during Q4 2022, and registered a low of $196.26 during Q3 2025.
  • Moreover, its 3-year median value for Revenue was $3,298 (2023), whereas its average is $1.8 million.
  • The largest annual percentage gain for Molecular Partners Ag's Revenue in the last 5 years was 17,213.30% (2022), contrasted with its biggest fall of 99.75% (2022).
  • Over the past 5 years, Molecular Partners Ag's Revenue (Quarterly) stood at $10.6 million in 2021, then skyrocketed by 1,751.45% to $196.6 million in 2022, then slumped by 95.97% to $7.9 million in 2023, then declined by 28.51% to $5.7 million in 2024, then slumped by 75.03% to $196.26 in 2025.
  • Its Revenue stands at $196.26 for Q3 2025, versus $4.2 million for Q2 2025 and $1,259 for Q1 2025.